HERANBAHeranba Industries Limited
Metals · Agricultural Inputs · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Heranba Industries Limited manufactures and sells various agrochemicals in India and internationally. It offers intermediates, such as cypermethric acid chloride (CMAC), high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benzaldehyde and benzyl alcohol, and NPBR; and insecticides, including cypermethrin, deltamethrin, alpha cypermethrin, tolfenpyrad, lambda cyhalothrin, permethrin, profenophos, dinotefuran, temephos, theta cypermethrin, diflubenzuron, ethion, methamidophos, thiophanate-methyl, and bifenthrin. The company also provides fungicides comprising tricyclazole, hexaconazole, tebuconazole, thifluzamide, propiconazole, picoxystrobin, and dodine; herbicides consisting of bispyribac sodium, clodinafop, tembotorine, and pendimethalin; and plant growth regulators. In addition, it offers formulations, such as emulsifiable concentrate, capsule suspension, suspension concentrate, oil dispersion, concentrated aqueous emulsions, wettable powder, suspoemulsion, water dispersible granule, ZC formulation, soluble liquid, flowable concentration, and soluble powder. The company was formerly known as Heranba Industrial Chemicals Limited and changed its name to Heranba Industries Limited in July 1996. Heranba Industries Limited was incorporated in 1992 and is based in Mumbai, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on HERANBA — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Overall evidence is weak (AlgoScore 22/100)
- • Revenue growth: -15.3% YoY
- • ROE: -10.0%
- • RSI: 27
- • MACD: bearish
Bull case
- • Profit growth: 16.3% YoY
- • Debt/Equity: 0.75
- • Promoter holding: 74.9%
- • Beta: 0.51
Bear case
- • Revenue growth: -15.3% YoY
- • ROE: -10.0%
- • RSI: 27
- • MACD: bearish
Key risks
- • Weak fundamentals — technical strength may not sustain
- • Momentum is fading versus the broader market
- • Revenue growth: -15.3% YoY
- • ROE: -10.0%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹6.89). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.